StockData
Xencor Inc logo

Xencor Inc (XNCR) stock

XNCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30194% above fair value
$34.50−0.90 (-2.54%)

Close on Nov 17, 2026Market cap $2.57BP/E –Yield –

Xencor gross margin

Gross margin is gross profit as a percentage of revenue.

No gross margin figures for Xencor

Xencor has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Xencor figures

See a number that looks wrong?